Prostacyclin production by different human grafts employed in coronary operations

Ann Thorac Surg. 1994 May;57(5):1147-50. doi: 10.1016/0003-4975(94)91345-5.

Abstract

Segments of human saphenous vein, internal mammary artery, right gastroepiploic artery, and inferior epigastric artery were incubated in vitro in Krebs-Henseleit solution and compared in terms of their capacity to generate and release into the medium 6-keto-prostaglandin F1 alpha (PGF1 alpha), the stable metabolite of prostacyclin. The four vascular conduits were also challenged with endothelin-1 (40 ng/mL), and accumulation of the lipidic material in the bathing fluid was also studied. The results obtained show clearly that under both normal and endothelin-1-stimulated conditions, the four vascular segments generate a substantial amount of 6-keto-PGF1 alpha. Multiple-comparisons analysis of the results indicates that the rank order in producing 6-keto-PGF1 alpha is as follows: inferior epigastric artery > internal mammary artery > right gastroepiploic artery > saphenous vein (p < 0.01). A similar order of potency was obtained in vascular conduits stimulated with endothelin-1. The rate of formation of immunoreactive 6-keto-PGF1 alpha under both normal and stimulated conditions by the inferior epigastric artery (normal, 301 +/- 8 pg/mg of tissue; stimulated, 519 +/- 15 pg/mg of tissue) was at 10 minutes more than 2 times (p < 0.01) that of the saphenous vein and about 1.5 times (p < 0.01) that of the right gastroepiploic artery.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / biosynthesis
  • Abdominal Muscles / blood supply
  • Aged
  • Arteries / metabolism
  • Arteries / transplantation
  • Blood Vessels / metabolism*
  • Blood Vessels / transplantation*
  • Endothelins / pharmacology
  • Epoprostenol / biosynthesis*
  • Humans
  • In Vitro Techniques
  • Male
  • Mammary Arteries / metabolism
  • Mammary Arteries / transplantation
  • Middle Aged
  • Myocardial Revascularization*
  • Saphenous Vein / metabolism
  • Saphenous Vein / transplantation

Substances

  • Endothelins
  • 6-Ketoprostaglandin F1 alpha
  • Epoprostenol